Spyre Therapeutics, Inc. - Common Stock (SYRE) — AI analysis & news
Spyre Therapeutics, Inc. - Common Stock (SYRE) stock: 7 recent news items, slightly negative aggregate sentiment, AI analysis and market context on…
Current sentiment read
Across the last 7 indexed SYRE stories, aggregate finance-aware sentiment is slightly negative (-0.17 on a -1 to +1 scale).
Latest SYRE news
- Spyre Therapeutics stock falls on public offering launch By Investing.com - Investing.com South Africa · Investing.com South Africa
- Spyre Therapeutics stock falls on public offering launch By Investing.com - Investing.com UK · Investing.com UK
- Form 4 Spyre Therapeutics Inc For: 2 October By Investing.com - Investing.com Australia · Investing.com Australia
- Form 4 Spyre Therapeutics Inc For: 2 October By Investing.com - Investing.com UK · Investing.com UK
- Spyre Therapeutics CEO Cameron Turtle sells $1.38m in SYRE stock - Investing.com India · Investing.com India
- Spyre Therapeutics CEO Cameron Turtle sells $1.38m in SYRE stock - Investing.com UK · Investing.com UK
- Why is Spyre Therapeutics stock climbing today? - Investing.com · Investing.com
FAQ
What is the current sentiment for SYRE stock?
Aggregate finance-aware sentiment across the last 7 indexed SYRE news stories is slightly negative (-0.17 on a -1 to +1 scale).